AP3307A - Heteroaryl compounds as 5-HT4 receptor ligands - Google Patents
Heteroaryl compounds as 5-HT4 receptor ligandsInfo
- Publication number
- AP3307A AP3307A AP2013007301A AP2013007301A AP3307A AP 3307 A AP3307 A AP 3307A AP 2013007301 A AP2013007301 A AP 2013007301A AP 2013007301 A AP2013007301 A AP 2013007301A AP 3307 A AP3307 A AP 3307A
- Authority
- AP
- ARIPO
- Prior art keywords
- receptor ligands
- heteroaryl compounds
- heteroaryl
- compounds
- ligands
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Semiconductor Integrated Circuits (AREA)
- Structures Or Materials For Encapsulating Or Coating Semiconductor Devices Or Solid State Devices (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN3203CH2011 | 2011-09-19 | ||
PCT/IN2012/000011 WO2013042135A1 (en) | 2011-09-19 | 2012-01-05 | Heteroaryl compounds as 5-ht4 receptor ligands |
Publications (2)
Publication Number | Publication Date |
---|---|
AP2013007301A0 AP2013007301A0 (en) | 2013-12-31 |
AP3307A true AP3307A (en) | 2015-06-30 |
Family
ID=46001349
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AP2013007301A AP3307A (en) | 2011-09-19 | 2012-01-05 | Heteroaryl compounds as 5-HT4 receptor ligands |
Country Status (26)
Country | Link |
---|---|
US (2) | US9079894B2 (it) |
EP (1) | EP2758394B1 (it) |
JP (1) | JP5714729B2 (it) |
KR (1) | KR101551481B1 (it) |
CN (1) | CN103380131B (it) |
AP (1) | AP3307A (it) |
AU (1) | AU2012311057B2 (it) |
BR (1) | BR112014001083B8 (it) |
CA (1) | CA2823548C (it) |
CY (1) | CY1116173T1 (it) |
DK (1) | DK2758394T3 (it) |
EA (1) | EA022374B1 (it) |
ES (1) | ES2531885T3 (it) |
HK (1) | HK1187340A1 (it) |
HR (1) | HRP20150229T1 (it) |
IL (1) | IL231305A0 (it) |
ME (1) | ME02107B (it) |
MX (1) | MX337721B (it) |
PL (1) | PL2758394T3 (it) |
PT (1) | PT2758394E (it) |
RS (1) | RS53940B1 (it) |
SG (1) | SG2014003560A (it) |
SI (1) | SI2758394T1 (it) |
SM (1) | SMT201500087B (it) |
WO (1) | WO2013042135A1 (it) |
ZA (1) | ZA201309100B (it) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012169649A1 (en) * | 2011-06-07 | 2012-12-13 | Dainippon Sumitomo Pharma Co., Ltd. | Indazole- and pyrrolopyridine-derivative and pharmaceutical use thereof |
CN105120851A (zh) * | 2013-04-05 | 2015-12-02 | Abc生物科学公司 | 用于医疗用途,具体为用于治疗与氧化应激相关的疾病或者炎症和用于保存或者洗涤器官的barettin及其衍生物 |
US9951045B2 (en) * | 2013-12-16 | 2018-04-24 | Suven Life Sciences Limited | Indazole compounds as 5-HT4 receptor agonists |
DK3180333T3 (da) * | 2014-08-16 | 2020-09-28 | Suven Life Sciences Ltd | Fremgangsmåde til storstilet fremstilling af 1-isopropyl-3-{5- [1-(3-methoxypropyl)piperidin-4-yl]-[1,3,4]oxadiazol-2-yl}-1h-indazoloxalat |
BR112017017275A2 (pt) * | 2015-02-13 | 2018-04-17 | Suven Life Sciences Ltd | composto, composição farmacêutica, método para o tratamento e uso do composto |
CN107540568A (zh) * | 2017-08-25 | 2018-01-05 | 许昌恒生制药有限公司 | 一种乙氧酰胺苯甲酯的制备方法 |
KR20230155613A (ko) * | 2018-10-18 | 2023-11-10 | 수벤 라이프 사이언시스 리미티드 | 5-ht4 수용체 작용제의 새로운 용도 |
AU2020282759A1 (en) | 2019-05-31 | 2021-12-23 | Ikena Oncology, Inc. | TEAD inhibitors and uses thereof |
CN110746450A (zh) * | 2019-09-17 | 2020-02-04 | 济南康和医药科技有限公司 | 一种贝前列素钠关键中间体的合成方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997017345A1 (fr) * | 1995-11-09 | 1997-05-15 | Synthelabo | Derives de 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2(3h)-one, utiles comme ligands des recepteurs 5-ht4 ou h¿3? |
US20060194842A1 (en) * | 2005-02-22 | 2006-08-31 | Chikara Uchida | Oxyindole derivatives |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2363492A (en) * | 1991-08-03 | 1993-03-02 | Smithkline Beecham Plc | 5-ht4 receptor antagonists |
TW360653B (en) * | 1995-03-01 | 1999-06-11 | Janssen Pharmaceutica Nv | A oxadiazole compound having colon motility stimulating properties, its preparation process and its pharmaceutical composition |
GB0115862D0 (en) * | 2001-06-28 | 2001-08-22 | Smithkline Beecham Plc | Compounds |
CA2545092C (en) | 2003-11-24 | 2010-08-17 | Pfizer Inc. | Quinolonecarboxylic acid compounds having 5-ht4 receptor agonistic activity |
ES2523459T3 (es) | 2005-02-25 | 2014-11-26 | Raqualia Pharma Inc | Derivados de benzisoxazol |
US7906532B2 (en) | 2005-07-22 | 2011-03-15 | Pfizer Inc. | Indazole derivatives |
JP5015172B2 (ja) * | 2005-12-23 | 2012-08-29 | エフ.ホフマン−ラ ロシュ アーゲー | アリール−イソオキサゾロ−4−イル−オキサジアゾール誘導体 |
US20080167286A1 (en) * | 2006-12-12 | 2008-07-10 | Abbott Laboratories | Pharmaceutical compositions and their methods of use |
US20080255203A1 (en) * | 2007-04-12 | 2008-10-16 | Abbott Laboratories | Heterocyclic compounds and their methods of use |
JP5656880B2 (ja) * | 2009-03-09 | 2015-01-21 | グラクソ グループ リミテッドGlaxo Group Limited | Pi3キナーゼの阻害剤としての4−オキサジアゾール−2−イル−インダゾール |
-
2012
- 2012-01-05 PT PT127166627T patent/PT2758394E/pt unknown
- 2012-01-05 ES ES12716662.7T patent/ES2531885T3/es active Active
- 2012-01-05 SG SG2014003560A patent/SG2014003560A/en unknown
- 2012-01-05 AP AP2013007301A patent/AP3307A/xx active
- 2012-01-05 DK DK12716662.7T patent/DK2758394T3/en active
- 2012-01-05 WO PCT/IN2012/000011 patent/WO2013042135A1/en active Application Filing
- 2012-01-05 RS RS20150234A patent/RS53940B1/en unknown
- 2012-01-05 SI SI201230163T patent/SI2758394T1/sl unknown
- 2012-01-05 ME MEP-2015-47A patent/ME02107B/me unknown
- 2012-01-05 US US13/982,486 patent/US9079894B2/en active Active
- 2012-01-05 CA CA2823548A patent/CA2823548C/en active Active
- 2012-01-05 CN CN201280009072.1A patent/CN103380131B/zh active Active
- 2012-01-05 EA EA201391056A patent/EA022374B1/ru unknown
- 2012-01-05 BR BR112014001083A patent/BR112014001083B8/pt not_active IP Right Cessation
- 2012-01-05 EP EP12716662.7A patent/EP2758394B1/en active Active
- 2012-01-05 AU AU2012311057A patent/AU2012311057B2/en active Active
- 2012-01-05 PL PL12716662T patent/PL2758394T3/pl unknown
- 2012-01-05 MX MX2013014577A patent/MX337721B/es active IP Right Grant
- 2012-01-05 KR KR1020137020582A patent/KR101551481B1/ko active IP Right Grant
- 2012-01-05 JP JP2013554062A patent/JP5714729B2/ja active Active
-
2013
- 2013-12-04 ZA ZA2013/09100A patent/ZA201309100B/en unknown
-
2014
- 2014-01-10 HK HK14100305.4A patent/HK1187340A1/zh unknown
- 2014-03-04 IL IL231305A patent/IL231305A0/en active IP Right Grant
-
2015
- 2015-02-26 HR HRP20150229AT patent/HRP20150229T1/hr unknown
- 2015-03-30 CY CY20151100308T patent/CY1116173T1/el unknown
- 2015-04-09 SM SM201500087T patent/SMT201500087B/it unknown
- 2015-06-10 US US14/735,237 patent/US9636335B2/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997017345A1 (fr) * | 1995-11-09 | 1997-05-15 | Synthelabo | Derives de 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2(3h)-one, utiles comme ligands des recepteurs 5-ht4 ou h¿3? |
US20060194842A1 (en) * | 2005-02-22 | 2006-08-31 | Chikara Uchida | Oxyindole derivatives |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL286152A (en) | Modified imidazopyridinyl-aminopyridine compounds | |
GB201106799D0 (en) | Novel compounds | |
GB201107325D0 (en) | Novel compounds | |
AP3307A (en) | Heteroaryl compounds as 5-HT4 receptor ligands | |
EP2670746A4 (en) | BICYCLIC HETEROARYL COMPOUNDS AS GPR119 RECEPTOR AGONISTS | |
HK1187613A1 (en) | Compounds as histamine h3 receptor ligands h3 | |
EP2717694A4 (en) | NEW COMPOUNDS | |
HK1180955A1 (en) | Heterocyclyl compounds as histamine h3 receptor ligands h3 | |
HUP1100731A2 (en) | Complex forming compounds | |
TH1401001203B (th) | สารประกอบเฮเทอโรเอริลในฐานะที่เป็น 5-ht4 รีเซปเตอร์ลิแกนด์ | |
TH148768B (th) | สารประกอบเฮเทอโรเอริลในฐานะที่เป็น 5-ht4 รีเซปเตอร์ลิแกนด์ | |
GB201118658D0 (en) | Novel compounds | |
GB201111409D0 (en) | Novel compounds | |
GB201111308D0 (en) | Novel compounds | |
GB201111229D0 (en) | Novel compounds | |
GB201109508D0 (en) | Novel compounds | |
GB201109514D0 (en) | Novel compounds | |
GB201106801D0 (en) | Novel compounds | |
GB201104138D0 (en) | Novel compounds | |
GB201103283D0 (en) | Novel compounds | |
GB201103073D0 (en) | Novel compounds | |
GB201101640D0 (en) | Novel compounds | |
GB201101085D0 (en) | Novel compounds |